| pubmed-article:19587388 | pubmed:articleTitle | Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. | lld:pubmed |
